More Musical Chairs For Device Center’s Higher-Ups
This article was originally published in The Gray Sheet
Executive Summary
During the final months under former FDA Commissioner Andrew von Eschenbach's leadership, the device center continued to tinker with its upper management, with more than 30 staffers either changing roles or leaving the agency since August (see chart: "1CDRH In Flux").